Patent Assignment
Reel/Frame 061945/0958
Change of Name
Recorded: 2022-12-01
Pages: 4
Assignor
BIOMEA FUSION, LLC
Executed: 2020-12-18
Assignee
BIOMEA FUSION, INC.
900 MIDDLEFIELD ROAD, 4TH FLOOR, REDWOOD CITY, CALIFORNIA, 94063
Covered Properties
(2)
Inhibitors of Menin-Mll Interaction
Covalent Inhibitors of Menin-Mll Interaction for Diabetes Mellitus
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 28, 2021
From: KELLY, BRENDAN; PALMER, JIM; UPASANI, RAVI; PAINTTER, EDWARD
To: NURIX THERAPEUTICS, INC.
Reel/Frame 057625/0874 →
Corrective Assignment to Correct the the Receiving Party Data Previously Recorded at Reel: 057625 Frame: 0874. Assignor(S) Hereby Confirms the Assignment.
Oct 10, 2021
From: BRENDAN, KELLY; PALMER, JIM; UPASANI, RAVI; EDWARD, PAINTER
To: BIOMEA FUSION, LLC
Reel/Frame 057759/0619 →
Assignment of Assignor's Interest
Oct 18, 2022
From: PALMER, JAMES T.; BUTLER, THOMAS
To: BIOMEA FUSION, INC
Reel/Frame 061703/0787 →
Assignment of Assignor's Interest
Nov 9, 2022
From: PALMER, JAMES T.; BUTLER, THOMAS
To: BIOMEA FUSION, INC.
Reel/Frame 061908/0157 →